Photodynamic Diagnosis of Actinic Keratosis: A Systematic Review
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0949Keywords:
actinic keratosis, photodiagnosis, photodynamic therapy, protoporphyrin IXAbstract
Actinic keratosis (AK) is a precancerous condition typically diagnosed by hyperkeratotic papules. The concept of field cancerization suggests subclinical lesions surround visible actinic keratoses. Photodynamic diagnosis (PDD)is a non-invasive imaging modality that can im-prove actinic keratosis diagnosis and treatment assessment. This systematic review describes current evidence regarding photodynamic diagnosis modalities for actinic keratosis. We searched MEDLINE and Embase through 28 February, 2025. Data synthesis was descriptive due to methodological heterogeneity across studies. Thirty-seven studies were included. Methyl aminolevulinate(MAL) and aminolevulinic acid (ALA)were used in 54% and 51% of studies, respectively. Incubation times ranged from 20 to 1080 min, 70 % of studies followed a 3 -h protocol. Most excitation sources (89%) emitted light within the 400–410 nm range, often via clinical-grade systems (54%). Imaging hardware varied: 54 % used integrated clinical systems, 30 % used independent cameras. Fluorescence quantification was described in 62 % of studies, and 54 % used specialized analysis software. Patient positioning was rarely reported (8%). This review highlights significant methodological heterogeneity in actinic keratosis photodynamic diagnosis, particularly in photosensitizer protocols and imaging systems. While clinical-grade systems provide standardization, low-cost alternatives enhance accessibility. However, lack of procedural consistency limits comparability. Future efforts should focus on advancing standardized protocols to support broader clinical validation and adoption.
Downloads
References
Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8–10. DOI: https://doi.org/10.1067/mjd.2000.103343
Khanna R, Bakshi A, Amir Y, Goldenberg G. Patient satisfaction and reported outcomes on the management of actinic keratosis. Clin Cosmet Investig Dermatol 2017; 10: 179–184. DOI: https://doi.org/10.2147/CCID.S121323
Richard MA, Amici JM, Basset-Seguin N, Claudel JP, Cribier B, Dreno B. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeamTM of expert clinicians. J Eur Acad Dermatol Venereol 2018; 32: 339–346. DOI: https://doi.org/10.1111/jdv.14753
Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol 2013; 68: S2–9. DOI: https://doi.org/10.1016/j.jaad.2012.09.052
Flohil SC, van der Leest RJT, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133: 1971–1978. DOI: https://doi.org/10.1038/jid.2013.134
Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222–229. DOI: https://doi.org/10.1016/0190-9622(95)90239-2
Malvehy J. A new vision of actinic keratosis beyond visible clinical lesions. J Eur Acad Dermatol Venereol 2015; 29 Suppl 1: 3–8. DOI: https://doi.org/10.1111/jdv.12833
Willenbrink TJ, Ruiz ES, Cornejo CM, Schmults CD, Arron ST, Jambusaria-Pahlajani A. Field cancerization: definition, epidemiology, risk factors, and outcomes. J Am Acad Dermatol 2020; 83: 709–717. DOI: https://doi.org/10.1016/j.jaad.2020.03.126
Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23–24. DOI: https://doi.org/10.1067/mjd.2000.103339
Marks R, Rennie G, Selwood Thomas S. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 331: 795–797. DOI: https://doi.org/10.1016/S0140-6736(88)91658-3
Huerta-Brogeras M, Olmos O, Borbujo J, Hernández-Núñez A, Castaño E, Romero-Maté A, et al. Validation of dermoscopy as a real-time noninvasive diagnostic imaging technique for actinic keratosis. Arch Dermatol 2012; 148: 1159–1164. DOI: https://doi.org/10.1001/archdermatol.2012.1060
Ulrich M, Maltusch A, Rius-Diaz F, Röwert-Huber J, González S, Sterry W, et al. Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses. Dermatol Surg 2008; 34: 610–619. DOI: https://doi.org/10.1111/j.1524-4725.2007.34117.x
Ulrich M, Krueger-Corcoran D, Roewert-Huber J, Sterry W, Stockfleth E, Astner S. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses. Dermatology 2010; 220: 15–24. DOI: https://doi.org/10.1159/000254893
Maier T, Braun-Falco M, Laubender RP, Ruzicka T, Berking C. Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol 2013; 168: 120–128. DOI: https://doi.org/10.1111/j.1365-2133.2012.11202.x
Boone MALM, Norrenberg S, Jemec GBE, Del Marmol V. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study. Exp Dermatol 2013; 22: 93–97. DOI: https://doi.org/10.1111/exd.12074
Ogien J, Tavernier C, Fischman S, Dubois A. Line-field confocal optical coherence tomography (LC-OCT): principles and practical use. Ital J Dermatol Venerol 2023; 158: 171–179. DOI: https://doi.org/10.23736/S2784-8671.23.07613-2
Lacarrubba F, Verzì AE, Polita M, Aleo A, Micali G. Line‐field confocal optical coherence tomography in the treatment monitoring of actinic keratosis with tirbanibulin: a pilot study. Acad Dermatol Venereol 2023; 37: e1131–3. DOI: https://doi.org/10.1111/jdv.19147
Yang X, Palasuberniam P, Kraus D, Chen B. Aminolevulinic acid-based tumor detection and therapy: molecular mechanisms and strategies for enhancement. IJMS 2015; 16: 25865–25880. DOI: https://doi.org/10.3390/ijms161025865
Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin 2007; 25: 5–14. DOI: https://doi.org/10.1016/j.det.2006.09.005
Ortonne JP, Gupta G, Ortonne N, Duteil L, Queille C, Mallefet P. Effectiveness of cross polarized light and fluorescence diagnosis for detection of sub‐clinical and clinical actinic keratosis during imiquimod treatment. Exp Dermatol 2010; 19: 641–647. DOI: https://doi.org/10.1111/j.1600-0625.2009.01047.x
Braathen LR, Morton CA, Basset‐Seguin N, Bissonnette R, Gerritsen MJP, Gilaberte Y, et al. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. Acad Dermatol Venereol 2012; 26: 1063–1066. DOI: https://doi.org/10.1111/j.1468-3083.2011.04432.x
Zeitouni NC, Schlesinger T, Kheterpal M, Jolly PS, Jagdeo J. 5-aminolevulinic acid photodynamic therapy for the treatment of basal and squamous cell carcinoma: a systematic review. Photodiagnosis Photodyn Ther 2025; 54: 104649. DOI: https://doi.org/10.1016/j.pdpdt.2025.104649
Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275–292.
Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997; 133: 727–732. DOI: https://doi.org/10.1001/archderm.1997.03890420065007
Piffaretti F, Zellweger M, Kasraee B, Barge J, Salomon D, van den Bergh H, et al. Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy. Dermatology 2013; 227: 214–225. DOI: https://doi.org/10.1159/000353775
van der Beek N, de Leeuw J, Demmendal C, Bjerring P, Neumann HAM. PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alone in fluorescence detection of non-melanoma skin cancer: an intra-patient direct comparison study. Lasers Surg Med 2012; 44: 271–276. DOI: https://doi.org/10.1002/lsm.21134
Wiegell SR, Petersen B, Wulf HC. Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial. Br J Dermatol 2016; 174: 979–984. DOI: https://doi.org/10.1111/bjd.14465
Smits T, Kleinpenning MM, Blokx WAM, van de Kerkhof PCM, van Erp PEJ, Gerritsen MJP. Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Dermatol 2007; 57: 824–831. DOI: https://doi.org/10.1016/j.jaad.2007.06.031
Rossi A, Garelli V, Pranteda G, Cardone M, Anzalone A, Fortuna MC, et al. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization. J Photochem Photobiol B 2016; 162: 72–76. DOI: https://doi.org/10.1016/j.jphotobiol.2016.06.028
de Leeuw J, van der Beek N, Neugebauer WD, Bjerring P, Neumann HAM. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage. Lasers Surg Med 2009; 41: 96–103. DOI: https://doi.org/10.1002/lsm.20739
Tyrrell J, Campbell SM, Curnow A. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Photodiagnosis Photodyn Ther 2011; 8: 30–38. DOI: https://doi.org/10.1016/j.pdpdt.2010.11.001
Bobyr I, Campanati A, Giacchetti A, Offidani A. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis. Photoderm Photoimm Photomed 2019; 35: 277–279. DOI: https://doi.org/10.1111/phpp.12452
Tyrrell J, Campbell S, Curnow A. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT. Photodiagnosis Photodyn Ther 2010; 7: 86–97. DOI: https://doi.org/10.1016/j.pdpdt.2010.03.002
Sorbellini E, Marzani B, Pinto D, Rinaldi F. Actinic keratosis prevention – A double-blind, half-face interventional study with a topical treatment. JST 2018; 9: 1. DOI: https://doi.org/10.5430/jst.v9n1p1
Bartosińska J, Szczepanik-Kułak P, Raczkiewicz D, Niewiedzioł M, Gerkowicz A, Kowalczuk D, et al. Topical photodynamic therapy with different forms of 5-aminolevulinic acid in the treatment of actinic keratosis. Pharmaceutics 2022; 14: 346. DOI: https://doi.org/10.3390/pharmaceutics14020346
Tyrrell J, Paterson C, Curnow A. Regression analysis of protoporphyrin IX measurements obtained during dermatological photodynamic therapy. Cancers 2019; 11: 72. DOI: https://doi.org/10.3390/cancers11010072
Kim BK, Lee NR, Park SY, Eom M, Choi EH. Efficacy of photodynamic therapy with laser pretreatment for actinic keratosis and photorejuvenation as evaluated by fluorescent imaging. Photoderm Photoimm Photomed 2015; 31: 36–43. DOI: https://doi.org/10.1111/phpp.12140
Korecka K, Polańska A, Dańczak-Pazdrowska A, Navarrete-Dechent C. Assessing field cancerization and actinic keratosis using ultraviolet-induced fluorescence dermatoscopy after the application of 5-aminolevulinic acid - an observational study. Photodiagnosis Photodyn Ther 2024; 46: 104056. DOI: https://doi.org/10.1016/j.pdpdt.2024.104056
Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001; 45: 96–104. DOI: https://doi.org/10.1067/mjd.2001.114288
Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Hædersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166: 1262–1269. DOI: https://doi.org/10.1111/j.1365-2133.2012.10893.x
Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151: 1204–1212. DOI: https://doi.org/10.1111/j.1365-2133.2004.06211.x
Li L, Li Y, Dong H, Yan J, Zhang Y, Zhang C, et al. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis. Photodiagnosis Photodyn Ther 2024; 47: 104100. DOI: https://doi.org/10.1016/j.pdpdt.2024.104100
Willey A. Thermal photodynamic therapy for actinic keratoses on facial skin: a proof-of-concept study. Dermatol Surg 2019; 45: 404–410. DOI: https://doi.org/10.1097/DSS.0000000000001702
Petersen B, Wiegell SR, Wulf HC. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study. Br J Dermatol 2014; 171: 175–178. DOI: https://doi.org/10.1111/bjd.12882
Tyrrell JS, Campbell SM, Curnow A. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 2010; 42: 613–619. DOI: https://doi.org/10.1002/lsm.20943
Regin Wiegell S, Hædersdal M, Christian Wulf H. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 2009; 89: 145–149. DOI: https://doi.org/10.2340/00015555-0568
Smits T, Robles CA, van Erp PEJ, van de Kerkhof PCM, Gerritsen MJP. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 2005; 125: 833–839. DOI: https://doi.org/10.1111/j.0022-202X.2005.23843.x
Wiegell SR, Petersen B, Wulf HC. Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial. Br J Dermatol 2014; 171: 1487–1492. DOI: https://doi.org/10.1111/bjd.13284
Buinauskaite E, Zalinkevicius R, Buinauskiene J, Valiukeviciene S. Pain during topical photodynamic therapy of actinic keratoses with 5‐aminolevulinic acid and red light source: randomized controlled trial. Photoderm Photoimm Photomed 2013; 29: 173–181. DOI: https://doi.org/10.1111/phpp.12044
Fauteck JD, Ackermann G, Birkel M, Breuer M, Moor ACE, Ebeling A, et al. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res 2008; 300: 53–60. DOI: https://doi.org/10.1007/s00403-007-0787-0
Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727–733. DOI: https://doi.org/10.1111/j.1365-2133.2008.08451.x
Fernández-Guarino M, Mavura D, Fernández-González P, Chapa P, Ravazzano C, Jaén L, et al. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa. Photodiagnosis Photodyn Ther 2020; 29: 101631. DOI: https://doi.org/10.1016/j.pdpdt.2019.101631
Kulyk O, Ibbotson SH, Moseley H, Valentine RM, Samuel IDW. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin. Photodiagnosis Photodyn Ther 2015; 12: 630–639. DOI: https://doi.org/10.1016/j.pdpdt.2015.10.002
Neittaanmäki-Perttu N, Grönroos M, Tani T, Pölönen I, Ranki A, Saksela O, et al. Detecting field cancerization using a hyperspectral imaging system. Lasers Surg Med 2013; 45: 410–417. DOI: https://doi.org/10.1002/lsm.22160
Blake E, Allen J, Thorn C, Shore A, Curnow A. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy. Lasers Med Sci 2013; 28: 997–1005. DOI: https://doi.org/10.1007/s10103-012-1188-y
Puizina-Ivić N, Zorc H, Vanjaka-Rogosić L, Mirić L, Persin A. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Coll Antropol 2008; 32 Suppl 2: 67–73.
Szeimies RM, Landthaler M. Photodynamic therapy and fluorescence diagnosis of skin cancers. Recent Results Cancer Res 2002; 160: 240–245. DOI: https://doi.org/10.1007/978-3-642-59410-6_28
Sieroń A, Kawczyk-Krupka A, Cebula MAW, Szyguła M, Zieleżnik W, Gruk M, et al. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of malignant skin tumors. Photodiagnosis Photodyn Ther 2004; 1: 311–317. DOI: https://doi.org/10.1016/S1572-1000(04)00069-9
Additional Files
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
